| Distinct genomic alterations in prostate cancers in Chinese and Western populations suggest alternative pathways of prostate carcinogenesis X Mao, Y Yu, LK Boyd, G Ren, D Lin, T Chaplin, SC Kudahetti, ... Cancer research 70 (13), 5207-5212, 2010 | 185 | 2010 |
| Validation of an RNA cell cycle progression score for predicting death from prostate cancer in a conservatively managed needle biopsy cohort J Cuzick, S Stone, G Fisher, ZH Yang, BV North, DM Berney, L Beltran, ... British journal of cancer 113 (3), 382-389, 2015 | 168 | 2015 |
| Validation of an RNA cell cycle progression score for predicting death from prostate cancer in a conservatively managed needle biopsy cohort J Cuzick, S Stone, G Fisher, ZH Yang, BV North, DM Berney, L Beltran, ... British journal of cancer 113 (3), 382-389, 2015 | 168 | 2015 |
| Validation of a contemporary prostate cancer grading system using prostate cancer death as outcome DM Berney, L Beltran, G Fisher, BV North, D Greenberg, H Møller, ... British journal of cancer 114 (10), 1078-1083, 2016 | 154 | 2016 |
| The outcome of patients treated with sunitinib prior to planned nephrectomy in metastatic clear cell renal cancer T Powles, C Blank, S Chowdhury, S Horenblas, J Peters, J Shamash, ... European urology 60 (3), 448-454, 2011 | 136 | 2011 |
| Prognostic and therapeutic impact of argininosuccinate synthetase 1 control in bladder cancer as monitored longitudinally by PET imaging MD Allen, P Luong, C Hudson, J Leyton, B Delage, E Ghazaly, R Cutts, ... Cancer research 74 (3), 896-907, 2014 | 133 | 2014 |
| The safety and efficacy of sunitinib before planned nephrectomy in metastatic clear cell renal cancer T Powles, I Kayani, C Blank, S Chowdhury, S Horenblas, J Peters, ... Annals of Oncology 22 (5), 1041-1047, 2011 | 108 | 2011 |
| Absolute quantitation of DNA methylation of 28 candidate genes in prostate cancer using pyrosequencing N Vasiljević, K Wu, AR Brentnall, DC Kim, MA Thorat, SC Kudahetti, ... Disease markers 30 (4), 151-161, 2011 | 105 | 2011 |
| Safety and efficacy of pazopanib therapy prior to planned nephrectomy in metastatic clear cell renal cancer T Powles, N Sarwar, A Stockdale, SJ Sarker, E Boleti, A Protheroe, ... JAMA oncology 2 (10), 1303-1309, 2016 | 82 | 2016 |
| The effect of VEGF-targeted therapy on biomarker expression in sequential tissue from patients with metastatic clear cell renal cancer K Sharpe, GD Stewart, A Mackay, C Van Neste, C Rofe, D Berney, ... Clinical Cancer Research 19 (24), 6924-6934, 2013 | 79 | 2013 |
| High‐resolution genome‐wide copy‐number analysis suggests a monoclonal origin of multifocal prostate cancer LK Boyd, X Mao, L Xue, D Lin, T Chaplin, SC Kudahetti, E Stankiewicz, ... Genes, Chromosomes and Cancer 51 (6), 579-589, 2012 | 71 | 2012 |
| Composite Hodgkin lymphoma and mantle cell lymphoma: two clonally unrelated tumors A Caleo, A Sánchez-Aguilera, S Rodríguez, AM Dotor, L Beltrán, ... The American journal of surgical pathology 27 (12), 1577-1580, 2003 | 60 | 2003 |
| Activity of inducible and neuronal nitric oxide synthases in colonic mucosa predicts progression of ulcerative colitis L Menchén, AL Colón, JLM Madrigal, L Beltrán, S Botella, I Lizasoain, ... Official journal of the American College of Gastroenterology| ACG 99 (9 …, 2004 | 43 | 2004 |
| Impact of the combination of durvalumab (MEDI4736) plus olaparib (AZD2281) administered prior to surgery in the molecular profile of resectable urothelial bladder cancer … JF Rodriguez-Moreno, G de Velasco, I Bravo Fernandez, ... Journal of Clinical Oncology 38 (6_suppl), 542-542, 2020 | 40 | 2020 |
| Ki-67 is an independent predictor of prostate cancer death in routine needle biopsy samples: proving utility for routine assessments SF Kammerer-Jacquet, A Ahmad, H Møller, H Sandu, P Scardino, ... Modern Pathology 32 (9), 1303-1309, 2019 | 38 | 2019 |
| Heterogeneous response and progression patterns reveal phenotypic heterogeneity of tyrosine kinase inhibitor response in metastatic renal cell carcinoma SM Crusz, YZ Tang, SJ Sarker, W Prevoo, I Kiyani, L Beltran, J Peters, ... BMC medicine 14, 1-9, 2016 | 38 | 2016 |
| Chinese and Western prostate cancers show alternate pathogenetic pathways in association with ERG status L Xue, X Mao, G Ren, E Stankiewicz, SC Kudahetti, D Lin, L Beltran, ... American Journal of Cancer Research 2 (6), 736, 2012 | 25 | 2012 |
| Intraoperative cytologic diagnosis of chordoid meningioma. A case report. E Salinero, L Beltran, JR Costa Acta cytologica 48 (2), 259-263, 2004 | 21 | 2004 |
| Should reporting of peri-neural invasion and extra prostatic extension be mandatory in prostate cancer biopsies? correlation with outcome in biopsy cases treated conservatively AS Ahmad, V Parameshwaran, L Beltran, G Fisher, BV North, ... Oncotarget 9 (29), 20555, 2018 | 18 | 2018 |
| A randomized, double-blind phase II study evaluating cediranib versus cediranib and saracatinib in patients with relapsed metastatic clear-cell renal cancer (COSAK) T Powles, J Brown, J Larkin, R Jones, C Ralph, R Hawkins, S Chowdhury, ... Annals of Oncology 27 (5), 880-886, 2016 | 18 | 2016 |
